XTANT Medical develops, manufactures and markets biologics products to domestic and international markets. Bacterin’s proprietary methods optimize the growth factors in human allografts to create the ideal stem cell scaffold to promote bone, subchondral
repair and dermal growth. These products are used in a variety of applications including enhancing fusion in spine surgery, relief of back pain, promotion of bone growth in foot and ankle surgery, promotion of cranial healing following neurosurgery and subchondral repair in knee and other joint surgeries. XTANT’s
Medical Device division develops, employs, and licenses bioactive coatings for various medical device applications. XTANT’s strategic coating initiatives include antimicrobial coatings designed to inhibit biofilm formation and microbial contamination. For further information, please visit www.xtantmedical.com.
GSK Vaccines is one of the world’s leading vaccine manufacturers, supplying around 25% of the world’s vaccines. The GSK vaccines adjuvant produced in Hamilton is a key element in Cervarix, a vaccine used to prevent cervical cancer along with other candidate vaccines.
McLaughlin Research Institute is an independent, non-profit research organization. Research at the institute focuses on understanding the genetic control of normal development and disease susceptibility using the mouse as a model system. The institute fosters a collegial, interactive environment, minimizing bureaucratic impediments to research.